company background image
SILO

Silo Pharma NasdaqCM:SILO Stock Report

Last Price

US$2.71

Market Cap

US$8.5m

7D

5.5%

1Y

-71.5%

Updated

04 Feb, 2023

Data

Company Financials

SILO Stock Overview

Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research.

SILO fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

Silo Pharma, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Silo Pharma
Historical stock prices
Current Share PriceUS$2.71
52 Week HighUS$12.45
52 Week LowUS$2.35
Beta-0.76
1 Month Change5.46%
3 Month Change-27.87%
1 Year Change-71.53%
3 Year Change-86.47%
5 Year Changen/a
Change since IPO-97.70%

Recent News & Updates

Recent updates

Silo Pharma spikes on pre-clinical data for Alzheimer's candidate

Oct 20

Silo Pharma begins pre-IND process for topical ketamine formulation for fibromyalgia

Oct 03

Shareholder Returns

SILOUS BiotechsUS Market
7D5.5%-0.8%1.7%
1Y-71.5%4.4%-9.6%

Return vs Industry: SILO underperformed the US Biotechs industry which returned 4.5% over the past year.

Return vs Market: SILO underperformed the US Market which returned -8.5% over the past year.

Price Volatility

Is SILO's price volatile compared to industry and market?
SILO volatility
SILO Average Weekly Movement13.5%
Biotechs Industry Average Movement12.1%
Market Average Movement6.7%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: SILO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: SILO's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
20102Eric Weisblumhttps://silopharma.com

Silo Pharma. Inc., a developmental stage biopharmaceutical company, focuses on merging traditional therapeutics with psychedelic research. It is developing solutions to address various underserved conditions.

Silo Pharma, Inc. Fundamentals Summary

How do Silo Pharma's earnings and revenue compare to its market cap?
SILO fundamental statistics
Market CapUS$8.49m
Earnings (TTM)-US$3.31m
Revenue (TTM)US$72.10k

117.8x

P/S Ratio

-2.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
SILO income statement (TTM)
RevenueUS$72.10k
Cost of RevenueUS$5.84k
Gross ProfitUS$66.26k
Other ExpensesUS$3.37m
Earnings-US$3.31m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.05
Gross Margin91.90%
Net Profit Margin-4,587.04%
Debt/Equity Ratio0%

How did SILO perform over the long term?

See historical performance and comparison